Clinical trials of a variety of new "anti-Ai" drugs developed in Yunnan are performing well

a number of anti-AIDS new drugs in Yunnan research and development is progressing smoothly, a number of new drugs will gradually enter the clinical trial stageThe province's independent research and development of anti-AIDS Chinese medicine new drug "complex three yellow capsules" last year through clinical trials, is currently to the State Drug Administration to declare the new drug certificateYunnan is China's high incidence of AIDS, but also the "anti-AIDS" key provincesSince the end of the last century, Yunnan has identified the key research and research areas of AIDS on the basis of extensive and in-depth research, and has fully launched the AIDS prevention and control of science and technology projects, organized the implementation of the treatment of new AIDS drugs ,"complex three yellow capsules", "Aitsun" and other research and development and "anti-HIV drug development key technology research" and other major scientific research projectsNot long ago, one of the new anti-AIDS Chinese medicine "Satsan" (formerly known as "complex SH") in Thailand to complete the phase III clinical experimental research, achieved better resultsIn accordance with the requirements of China's NationalDrug RegistrationManagement Measures, the new drug will carry out preclinical research work, and has now obtained clinical trial research approvalIn addition, the anti-AIDS chinese medicine new drug "Chisle capsule" also completed all pre-clinical research work, is collating information ready to declare "drug clinical trial approval." Research and development of "penta-misoin", "carbon cocci" and "Flazin", "Chinese medicine positive anti-toxic capsules" and "DC 32" is accelerating the preclinical research work of new anti-AIDS drugsPreviously, the "complex three yellow capsules" synthesized by Huang Bai, licorice, huangYu, etc., have been
successfully completed clinical trials according to thestandards
of the GCPthe of the Yu'anHospital in the capital medical university, theof the PLA's 302Hospital, the of Beijing Ditan Hospital, the
Beijing Guang'anmen Hospital of Chinese Medicine and
the Chinese Academy of Medicine, the Chinese Academy of Medical Sciences The results showed that clinical trials of compound triyellow capsules to suppress HIV showed that the drug was effective against HIV and had no toxic side effects and adverse reactions human sesame This Yunnan independent research and development of anti-AIDS Chinese medicine new drugs will be in accordance with the relevant requirements to the State Food Drug administration supervision and approval of the "new drug certificate." (rereproduced from "China News Network")